From another view, PD1/PD-L1 signaling is also implicated in autoimmune diseases, whereby inhibiting PD1 or PD-L1 in mice accelerates the development of type 1 diabetes, although upregulating PD-L1 protects against it [16]. Here, CD274 is linked to autoimmune disease.